Lazari Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Buy |
16,238
+5
| +0% | +$928 | 1.13% | 17 |
|
|
2025
Q1 | $3.4M | Sell |
16,233
-274
| -2% | -$57.4K | 1.39% | 13 |
|
|
2024
Q4 | $2.93M | Sell |
16,507
-901
| -5% | -$160K | 1.17% | 15 |
|
|
2024
Q3 | $3.44M | Sell |
17,408
-159
| -0.9% | -$31.4K | 1.47% | 14 |
|
|
2024
Q2 | $3.01M | Sell |
17,567
-343
| -2% | -$58.8K | 1.36% | 13 |
|
|
2024
Q1 | $3.26M | Sell |
17,910
-265
| -1% | -$48.3K | 1.77% | 11 |
|
|
2023
Q4 | $2.82M | Sell |
18,175
-187
| -1% | -$29K | 1.61% | 12 |
|
|
2023
Q3 | $2.74M | Sell |
18,362
-481
| -3% | -$71.7K | 1.63% | 12 |
|
|
2023
Q2 | $2.54M | Buy |
+18,843
| New | +$2.54M | 1.43% | 14 |
|